INTRODUCTION {#S1}
============

Down syndrome (DS) is a neurodevelopmental disorder occurring in 1 in 750 live births worldwide. DS is caused by trisomy of chromosome 21 (Ts21) ([@R19]), leading to triplication of up to 400 genes, resulting in an array of phenotypes, including profoundly impaired cognitive function. The brains of DS patients demonstrate consistent pathophysiological changes, such as reduced volume, altered neuronal densities and structure, and disturbed balance of all cell types. Confronted with this genetic complexity, it is difficult to determine precise molecular and cellular mechanisms of disease establishment and maintenance. Consequently, there are no therapeutic approaches to mitigate the effects of DS.

To date, DS pathophysiology has been primarily studied in rodent models (Ts65Dn, Ts1cje, and Ts1Rhr; [@R15]). Though useful information has been revealed, rodent models do not faithfully reproduce DS pathophysiology, due in part to incomplete synteny between HSA21 and homologous mouse regions. Furthermore, rodent modeling of complex neurodevelopmental disorders, such as DS, is limited by the fact that the human brain is far more complicated than the rodent brain in terms of structure of the neural circuitry, plasticity, and cognitive capacity.

Advances in induced pluripotent stem cell (iPSC) technology have enabled the modeling of complex diseases, such as DS in the context of human cell biology ([@R14]; [@R33]; [@R51]). These models are highly desirable for understanding disease neuropathophysiology and for developing therapeutics. By culturing iPSCs from DS individuals, it is possible to achieve full expression of the human HSA21 region. In addition, the use of isogenic control lines eliminates inter-individual variability, restricting genotype differences solely to HSA21 dosage.

Recent studies using Ts21-iPSC-derived DS models have revealed deficits in human neurons or astroglia associated with DS ([@R14]; [@R22]; [@R33]; [@R39]). [@R51] established Ts21-iPSC lines from two sets of human fibroblasts and differentiated them into neurons. They found that Ts21-cortical neurons displayed reduced synaptic activity compared to control neurons, while maintaining the ratio of differentiated excitatory and inhibitory neurons. Furthermore, a recent follow-up study using similar model reported impaired migration of DS inhibitory neurons ([@R22]). [@R14], on the other hand, engineered Ts21 iPSCs from a different human fibroblast line and reported that conditioned medium from Ts21-iPSC-derived astroglia had a toxic effect on neuronal maturation and survival.

However, these studies only focus on morphological view of differentiated cells and examined neurons and astrocytes in isolation. Growing evidence suggests that astrocytes substantially contribute to neurological and psychiatric disorders by affecting neuronal function ([@R11]; [@R18]; [@R28]; [@R30]; [@R44]). Indeed, astrocytes have been implicated in multiple rodent studies as playing an important role in DS ([@R4]; [@R5]). A number of genes involved in DS, including *THBS1* and *APP,* have been shown to be expressed in astrocytes and have been implicated in Alzheimer's disease ([@R21]; [@R45]). A complete mechanistic understanding of DS pathophysiology requires studying the communication between neurons and astrocytes at the network level.

Unlike neurons, whose excitable membranes allow action potentials to be transmitted cell-wide within milliseconds, astrocyte-wide signaling occurs via intracellular calcium (Ca^2+^) transients lasting for seconds ([@R24]). These intracellular Ca^2+^ transients can be triggered by neuronal activity ([@R48]) and are thought to induce release of gliotransmitters ([@R3]; [@R27]; [@R32]; [@R35]), which in turn modulate neural activity. Although gliotransmitter identity and release mechanisms are controversial ([@R37]; [@R41]; [@R52]), intracellular Ca^2+^ dynamics are generally acknowledged to encode astrocyte activity. More importantly, altered astrocyte calcium dynamics were reported in cultured cells from the rodent DS models ([@R9]; [@R21]).

Based on these previous studies, we hypothesized that DS could affect neuronal excitability through altered astrocytic Ca^2+^ dynamics, leading to alterations in astrocyte-neuron signaling pathways. Therefore, we differentiated the Ts21-iPSC lines reported in [@R51] to astrocytes and neurons to establish a Ts21-iPSC-derived neuron-astrocyte co-culturing system to uncover functional deficits of neural networks. We focused on astrocytic Ca^2+^ dynamics and the specific interactions between astrocytes and neurons.

RESULTS {#S2}
=======

Generation and Differentiation of Astroglia from Human Ts21 iPSCs {#S3}
-----------------------------------------------------------------

Using established protocols ([@R26]), we differentiated astroglia from previously reported iPSC lines by [@R51], DS1 and DS4, which are trisomic for chromosome 21, and DS2U, a control isogenic line ([Figures S1A and S1B](#SD1){ref-type="supplementary-material"}). After 120 days, all three iPSC lines robustly expressed *CD44, GFAP,* and *AQP4* ([Figures S1D--S1F](#SD1){ref-type="supplementary-material"}; [Table S1](#SD1){ref-type="supplementary-material"}). Karyotype analysis prior to and after experiments confirmed trisomy of DS1- and DS4-derived astroglia (DS1A and DS4A) and disomy of DS2U-induced astroglia (DS2UA) ([Figure S1B](#SD1){ref-type="supplementary-material"}). Using qRT-PCR, we further observed global expression of a panel of astrocyte-specific markers, such as *EAAT1, ALDOC, CX43, SOX9,* and *NFIA,* in all three lines ([Figure S1C](#SD1){ref-type="supplementary-material"}; [Table S1](#SD1){ref-type="supplementary-material"}; [@R30]), indicating successful astroglia differentiation of the iPSCs. Consistent with previous reports, DS astroglia showed increased expression levels of HSA21 genes compared to control astroglia, including *S100B* ([@R20]), *APP* ([@R9]), and *ETS2* ([@R53]), as well as higher levels of non-HSA21 genes associated with oxidative stress, such as *CAT* ([@R8]) and *CRYZ* ([@R51]; [Figure S1C](#SD1){ref-type="supplementary-material"}; [Table S1](#SD1){ref-type="supplementary-material"}). Morphologically, DS astroglia occupied larger territories than DS2UA; the total arborization size of DS astrocytes was significantly greater than that of control isogenic astroglia ([Figure S1G](#SD1){ref-type="supplementary-material"}).

DS Astroglia Inhibit the Excitability of Co-cultured Neurons {#S4}
------------------------------------------------------------

We next studied the potential influence of DS astroglia on co-cultured neurons. Using established protocols ([@R12]; [@R54]), three lines of cortical TUJ1^+^ neurons were differentiated from the DS1 and DS2U iPSC lines and a control H9 human embryonic stem cell (hESC) line ([Figures S2A and S2B](#SD1){ref-type="supplementary-material"}). Differentiated neurons were infected with lentivirus encoding *synapsin-1* -GCaMP6m ([Figure S2D](#SD1){ref-type="supplementary-material"}). To establish a baseline of neuronal excitability, we monitored fluorescence changes in neurons in response to a series of electrically evoked field potentials (FPs) in the absence of astrocytes. The magnitude of evoked Ca^2+^ transients in neurons increased with the number of applied FPs ([Figure 1A](#F1){ref-type="fig"}). Evoked signals were abolished by addition of 1 μM tetrodotoxin (TTX) ([Figure 1A](#F1){ref-type="fig"}), suggesting that Ca^2+^ signals in neurons were triggered by action potentials. The expression of multiple voltage-gated sodium-channel isoforms in differentiated neurons was confirmed by qRT-PCR ([Figure S2E](#SD1){ref-type="supplementary-material"}).

After confirming the basis of neuronal excitability, we recorded neuronal activity when co-cultured with DS1-, DS4-, or DS2U-derived astroglia, as well as human primary astrocytes (HA) ([Figure S2C](#SD1){ref-type="supplementary-material"}). H9 hESC-derived neurons co-cultured with DS astroglia (DS1A or DS4A) showed significantly decreased FP-evoked Ca^2+^ amplitudes relative to neurons cultured alone (normalized ΔF/F; DS1A: 0.63 ± 0.06, p \< 0.01; DS4A: 0.57 ± 0.05, p \< 0.001), whereas neurons co-cultured with control isogenic astrocytes (DSU2A) or human primary astrocytes were not significantly affected (DS2UA: 1.00 ± 0.04, p = 0.93; HA: 0.88 ± 0.04, p = 0.059; [Figure 1B](#F1){ref-type="fig"}).

Similar neuronal-activity suppression imposed by DS astroglia was also observed in neurons derived from the two other iPSC lines. DS2U-derived neurons co-cultured with DS astroglia (DS1A or DS4A) showed significantly decreased FP-evoked Ca^2+^ amplitudes relative to neurons cultured alone (normalized ΔF/F; DS1A: 0.57 ± 0.04, p \< 0.001; DS4A: 0.51 ± 0.04, p \< 0.001; DS2UA: 0.99 ± 0.03, p = 0.89; HA: 0.93 ± 0.04, p = 0.18; [Figure 1C](#F1){ref-type="fig"}). Likewise, DS1-derived neurons cocultured with DS astroglia (DS1A or DS4A) showed significantly decreased FP-evoked Ca^2+^ amplitudes relative to neurons cultured alone (normalized ΔF/F; DS1A: 0.66 ± 0.07, p \< 0.01; DS4A: 0.43 ± 0.05, p \< 0.001; DS2UA: 0.92 ± 0.04, p = 0.15; HA: 0.95 ± 0.03; p = 0.18; [Figure 1D](#F1){ref-type="fig"}). Decreased neuronal activity in the presence of DS astroglia was observed under a variety of stimulation conditions but was most prominent during modest stimulation, such as 10FPs ([Figure S2F](#SD1){ref-type="supplementary-material"}). In addition, all co-cultured astrocytes significantly accelerated decay to baseline of evoked neuronal Ca^2+^ transients (T~0.5~ = 1.62 ± 0.14 for neuron-alone; 1.25 ± 0.12, 1.11 ± 0.13, and 1.18 ± 0.1 for neurons co-cultured with DS2UA, DS1A, and DS4A, respectively; p \< 0.01; [Figure S2G](#SD1){ref-type="supplementary-material"}). Taken together, DS astroglia inhibited neuronal excitability of neurons derived from either trisomy or disomy iPSC lines.

DS Astroglia Promote Synaptic Connectivity {#S5}
------------------------------------------

As DS astroglia suppress neuronal activity, we next sought to determine whether DS astroglia influence synaptic function. DS astroglia were co-cultured with dissociated rat hippocampal neurons, and miniature excitatory postsynaptic currents (mEPSCs) were recorded in the presence of TTX, NMDA receptor antagonist D-AP5, and GABA~A~ antagonist bicuculline (Figures [1E--1G](#F1){ref-type="fig"}, [S2H, and S2I](#SD1){ref-type="supplementary-material"}). Cumulative distribution plots showed that the mean amplitude of mEPSCs was significantly larger in neurons co-cultured with either DS4A or DS1A groups compared with control DS2UA (DS2UA: 14.21 ± 0.42; DS1A: 16.35 ± 0.78, p \< 0.05; DS4A: 16.26 ± 0.73, p \< 0.05; Figures [1F](#F1){ref-type="fig"} and [S2H](#SD1){ref-type="supplementary-material"}). mEPSC frequency was similar in all three groups, with a trend toward higher mEPSC frequencies in the neurons co-cultured with DS4A and DS1A groups (p = 0.204; DS2UA: 0.56 ± 0.06; DS1A: 1.29 ± 0.45; DS4A: 1.10 ± 0.36; Figures [1G](#F1){ref-type="fig"} and [S2I](#SD1){ref-type="supplementary-material"}). Next, using quantitative image analysis ([@R42]), we found that synapse density significantly increased by 1.5- and 1.3-fold in neurons co-cultured with DS astrocytes (DS1A, p \< 0.01 and DS4A, p \< 0.05, respectively) compared with those co-cultured with isogenic control astrocytes ([Figure 1H](#F1){ref-type="fig"}). Taken together, these results suggest that DS astroglia are capable of modulating neuronal excitability as well as synaptic activity and density.

Pharmacological Rescue of Suppressed Neuronal Excitability {#S6}
----------------------------------------------------------

We next examined whether pharmacological drugs that block astrocyte-neuron communication could rescue the suppressed neuronal excitability. We first examined a panel of small-molecule drugs that have been shown to rescue synaptic abnormalities in DS mouse models ([@R10]). These compounds, including purmorphamine (sonic hedgehog agonist), CGP52432 (GABA~B~R antagonist), epigallocatechin-3-gallate (EGCG) (DYRK1A inhibitor), fluoxetine (serotonin reuptake inhibitor), and memantine (NMDA receptor antagonist), however, failed to rescue decreased neuronal activity associated with DS astroglia (normalized ΔF/F = 0.60 ± 0.04, 0.68 ± 0.03, 0.70 ± 0.02, 0.71 ± 0.03, and 0.68 ± 0.06 from purmorphamine to memantine; p = 0.22, 0.95, 0.73, 0.67, and 0.93; n = 3; [Figure 1I](#F1){ref-type="fig"}).

We next tested whether suppressed neuronal excitability is caused by adenosine-mediated signaling that has been shown to inhibit synaptic activity ([@R1]; [@R17]; [@R23]; [@R25]; [@R34]). We treated H9 neurons co-cultured with DS astroglia (DS4A) with a G~i~-coupled A~1~ adenosine receptor antagonist, followed by imaging FP-evoked neuronal activity. In particular, the A~1~ receptor antagonist DPCPX fully rescued suppressed neuronal activity, especially at lower concentrations (100 nM: normalized ΔF/F = 1.20 ± 0.09, p \< 0.01; 1 μM: 0.98 ± 0.08, p \< 0.05; n = 3; [Figure 1I](#F1){ref-type="fig"}). We also treated H9 hESC derived with 100 μM adenosine, which resulted in suppressed neuronal activity after one hour incubation (normalized ΔF/F of 100 μM adenosine to without adenosine = 0.20 ± 0.06; p \< 0.01; [Figure S2J](#SD1){ref-type="supplementary-material"}). Furthermore, astroglia-conditioned medium (ACM) from DS4A also showed a trend of suppressed neuronal excitability compared to no ACM ([Figure S2K](#SD1){ref-type="supplementary-material"}).

DS Astroglia Exhibit Abnormally Frequent Spontaneous Ca^2+^ Fluctuations {#S7}
------------------------------------------------------------------------

Astrocytic Ca^2+^ signaling has been proposed to modulate neural-circuit activity and structure ([@R2]; [@R7]); the suppressed excitability of neurons was specific to DS astroglia and could be rescued when astrocyteneuron communication was blocked by an adenosine receptor antagonist. This evidence led us to further investigate Ca^2+^ dynamics in astroglia. We focused on optical recordings of calcium dynamics in astroglia using GCaMP6m ([@R13]). We used the machine-learning software Functional Astrocyte Phenotyping (FASP) ([@R50]) to facilitate automated detection and analysis of complex Ca^2+^ dynamics in astroglia.

The differentiated astroglia indeed displayed prominent spontaneous Ca^2+^ transients, which were frequently periodic and especially apparent in DS astroglia ([Figure 2A](#F2){ref-type="fig"}; [Videos S1](#SD2){ref-type="supplementary-material"} and [S2](#SD3){ref-type="supplementary-material"}). DS astroglia exhibited significantly more (7- to 34-fold) Ca^2+^ transients than control isogenic astroglia (averaged number of calcium transients in a 5-min imaging session: DS1A: 58 ± 6, DS4A: 275 ± 34, DS2UA: 8 ± 2; mean ± SEM; p \< 0.0001; unpaired t test; n = 9 imaging sessions; [Figure 2B](#F2){ref-type="fig"}). The average amplitude (ΔF/F; DS1A: 1.45 ± 0.2, DS4A: 0.98 ± 0.15; p \< 0.01; [Figure 2C](#F2){ref-type="fig"}) and frequency (transients/min; DS1A: 0.41 ± 0.10, DS4A: 0.88 ± 0.16; p \< 0.01; [Figure 2D](#F2){ref-type="fig"}) of Ca^2+^ transients were significantly different between DS1A and DS4A, whereas the kinetics were similar (T~1/2~, s; DS1A: 8.59 ± 1.01; DS4A: 6.98 ± 0.90; p = 0.18; [Figure 2E](#F2){ref-type="fig"}). These disparities are potentially due to epigenetic changes between the cell lines.

Inositol triphosphate (IP~3~)-triggered Ca^2+^ release from the endoplasmic reticulum (ER) is considered a primary mechanism responsible for intracellular global Ca^2+^ waves ([@R43]). Application of the IP~3~ receptor (IP~3~R) antagonist 2-aminoethoxydiphenyl borate (2-APB) abolished spontaneous Ca^2+^ fluctuations ([Figures 2F--2I](#F2){ref-type="fig"}), as did depletion of intracellular stores by cyclopiazonic acid (CPA), suggesting that IP~3~-ER Ca^2+^ underlies both spontaneous and evoked events in DS astroglia.

Wavefront analysis of the spontaneous events revealed 33 clusters of cells ([Figure S3A](#SD1){ref-type="supplementary-material"}, left) with temporally correlated Ca^2+^ fluctuations ([Figure S3A](#SD1){ref-type="supplementary-material"}, right) that were spatially intermingled ([Figure S3B](#SD1){ref-type="supplementary-material"}), suggesting that Ca^2+^ fluctuations do not propagate to adjacent cells. To further examine whether spontaneous fluctuations travel between cells, we performed Ca^2+^ imaging in a mixed culture of GCaMP6m-expressing control isogenic astroglia with unlabeled DS4A in a variety of ratios. Culturing with DS astroglia did not significantly increase the number of Ca^2+^ transients in control isogenic astroglia, even with a 10-fold excess of DS4A ([Figure S3C](#SD1){ref-type="supplementary-material"}), suggesting that spontaneous Ca^2+^ fluctuations were not induced in previously silent control isogenic cells. In addition, application of 10 μM *n*-octanol, a gap junction blocker, showed no effect on Ca^2+^fluctuations ([Figure S3D](#SD1){ref-type="supplementary-material"}).

Acutely purified human astrocytes acquire sensitivity to extracellular cues, such as neurotransmitter ATP and glutamate ([@R55]). To exclude the possibility that differences in functional maturation of differentiated astroglia contribute to suppressed neuronal excitability, we examined transmitter-evoked Ca^2+^ responses of DS astroglia and compared with isogenic controls. Only previously, silent astrocytes were selected for quantification of evoked responses in order to differentiate evoked from spontaneous activity. Both DS and control isogenic astroglia responded robustly to ATP (representative traces of evoked Ca^2+^ transients shown in [Figures S3E and S3F](#SD1){ref-type="supplementary-material"}) in terms of the number and amplitude of evoked intracellular Ca^2+^ transients. Similarly, both DS astroglia and control isogenic astroglia responded to glutamate at micromolar concentrations ([Figures S3G andS3H](#SD1){ref-type="supplementary-material"}). Thus, DS and control astroglia respond similarly to neurotransmitters, further suggesting that Ts21 does not influence functional maturation of differentiated astrocytes.

Blocking Spontaneous Ca^2+^ Fluctuations in DS Astroglia Rescues Suppressed Neuronal Excitability {#S8}
-------------------------------------------------------------------------------------------------

We tested whether the suppression of neuronal activity might be caused by the abnormally frequent spontaneous Ca^2+^ fluctuations observed in DS astroglia. Because pharmacological block of IP~3~ receptors abrogated spontaneous Ca^2+^ waves ([Figures 2F--2I](#F2){ref-type="fig"}), we knocked down (KD) the expression of *IP*~*3*~*R2* in DS astroglia DS4A alone, the main *IP*~*3*~*R* isoform in astrocytes, with short hairpin RNAs (shRNAs). *IP*~*3*~*R2* KD in DS astroglia DS4A ([Figure 3B](#F3){ref-type="fig"}) significantly reduced the number of active regions of interest (ROIs) showing spontaneous Ca^2+^ transients (scrambled shRNA: 61.0 ± 3.8; *IP*~*3*~*R2* shRNA-1: 21.3 ± 2.4 \[35%\]; *IP*~*3*~*R2* shRNA-2: 14.3 ± 1.8 \[24%\]; p \< 0.001; [Figures 3A and 3C](#F3){ref-type="fig"}).

We then imaged the activity of neurons co-cultured with DS4A astroglia with *IP*~*3*~*R2* knocked down, which rescued the reduced amplitude of evoked neuronal Ca^2+^ transients (measured as normalized ΔF/F; *IP*~*3*~*R2* shRNA-1: 0.91 ± 0.0.4; shRNA-2: 0.93 ± 0.03) to the level of isogenic control astroglia (1.01 ± 0.04; p = 0.28). In contrast, DS4A with no shRNA (0.60 ± 0.05; p \< 0.01) or control-scrambled shRNA (0.62 ± 0.04; p \< 0.01) showed significantly decreased neural activity ([Figure 3D](#F3){ref-type="fig"}). Therefore, elevated intracellular Ca^2+^ fluctuation mediated by IP~3~R2 is necessary to suppress neuronal excitability.

Spontaneous Ca^2+^ Fluctuations in DS Astroglia Are Not Driven by Extracellular Cues {#S9}
------------------------------------------------------------------------------------

As elevated spontaneous astroglia Ca^2+^ activity directly contributed to suppressed neuronal activity, we next sought to determine the factors driving elevated Ca^2+^ activity in DS astroglia. We first performed single-cell analysis of gene expression related to Ca^2+^ signaling pathways ([Figure S4A](#SD1){ref-type="supplementary-material"}) in DS astroglia. We also monitored the expression of a panel of astrocytic markers to account for the differentiation state of individual cells ([Figures S4A and S4B](#SD1){ref-type="supplementary-material"}). We then performed unsupervised clustering analysis of the cells by their gene expression patterns. We found that DS astroglia (DS4A) clustered into two groups ([Figure S4C](#SD1){ref-type="supplementary-material"}), distinguished by elevated expression of Ca^2+^ handling genes, such as *ATP2B1*, *NCX1, RYR1/3, STIM1, NCLX, IP3R3, ORAI1,* and chromosome 21 gene *S100B* ([Table S1](#SD1){ref-type="supplementary-material"}). This suggests that a subset of DS astroglia may display elevated spontaneous Ca^2+^ fluctuations. In DS astroglia, astrocytic markers, such as *CD44, CX43, AQP4, NF1A,* and *ALDOC,* were not differentially expressed between the two clusters. In contrast, we failed to identify significant clustering ([Figure S4D](#SD1){ref-type="supplementary-material"}) of genes related to the Ca^2+^-handling toolkit in control isogenic astroglia (DS2UA).

Moreover, from the single-cell gene analysis, we found that metabotropic glutamate receptors (*GRM1/2/3/4/5/6/7/8*) and purinergic receptors were elevated in a subset of DS4UA. We next investigated whether spontaneous fluctuations in DS astroglia could be modulated by pharmacological manipulation of these receptors. ATP treatment led to a 2-fold increase in the frequency and a 1.4-fold increase in the amplitude of spontaneous Ca^2+^ fluctuations in \~40% of ROIs ([Figure 4A](#F4){ref-type="fig"}). However, treatment with P2-isotype-specific ATP receptor antagonists (PPADS for P2X; MRS2179for P2Y; Figures [4B](#F4){ref-type="fig"} and [S5A](#SD1){ref-type="supplementary-material"}), non-specific P2 antagonists (suramin; [Figure 4C](#F4){ref-type="fig"}), or an adenosine A~1~-receptor antagonist (DPCPX; [Figure 4D](#F4){ref-type="fig"}) had no significant effect on spontaneous Ca^2+^ fluctuations, suggesting that, although ATP can modulate spontaneous Ca^2+^ events in DS astroglia, it is not necessary to evoke them. CHPG (a selective mGluR5 agonist) showed no significant effects on amplitude, frequency, or kinetics of spontaneous Ca^2+^ fluctuations ([Figure S5B](#SD1){ref-type="supplementary-material"}). Similarly, mGluR5-selective (MPEP), non-selective mGluR (MCPG), and mGluR2/3-selective (LY341495) antagonists, as well as a glutamate transporter inhibitor (TFB-TBOA), also had no effect (Figures [4E](#F4){ref-type="fig"} and [S5C--S5E](#SD1){ref-type="supplementary-material"}). The TRPA1 channel antagonist HC030031 also had no significant effect on spontaneous Ca^2+^ fluctuations ([Figure 4F](#F4){ref-type="fig"}), consistent with the lack of microdomain Ca^2+^ activity observed ([@R40]). In summary, whereas both intrinsically and extrinsically driven calcium transients depend on IP~3~-mediated release from ER stores, our results suggest that spontaneous fluctuations are unlikely to be driven, though can be modified, by extracellular cues.

S100B Regulates Spontaneous Ca^2+^ Fluctuations in DS Astroglia {#S10}
---------------------------------------------------------------

From gene analysis, we also noticed that *S100B*, a Ca^2+^-binding protein located on HSA21 and primarily expressed in astrocytes, was one of the top genes differentially expressed across DS4A cells. S100B elicits neurotrophic effects and regulates synaptic plasticity and rhythmic neuronal activity by chelating extracellular calcium ([@R31]; [@R36]). Given the particular interest in the context of Ts21 DS, we thus asked whether elevated S100B might contribute to the spontaneous intracellular Ca^2+^ fluctuations in DS astroglia.

We first quantified the expression level of *S100B* in Ts21-derived astroglia. qRT-PCR analysis showed an averaged 11-fold greater expression of *S100B* in DS astroglia (DS1A and DS4A) compared with control isogenic DS2UA cells ([Figure S1C](#SD1){ref-type="supplementary-material"}). Expression of S100B protein was enriched in DS astroglia compared to DS2UA ([Figures 5A and 5B](#F5){ref-type="fig"}; 9.9- and 10.7-fold increased expression S100B for DS1A and DS4A, respectively, compared to DS2UA).

We next selectively knocked down *S100B* in DS4A and performed Ca^2+^ imaging. Using mCherry as a proxy for the extent of *S100B* KD, we used fluorescence-activated cell sorting (FACS) to select the top 15% of cells showing potent *S100B* KD and use the bottom 15% of cells as a control group showing normal S100B levels ([Figures 5C--5F](#F5){ref-type="fig"}). The *S100B* KD population showed a 3.5-fold decrease in spontaneous Ca^2+^ transients during a 5-min window (p \< 0.001; [Figures 5D and 5F](#F5){ref-type="fig"}), which corresponds to \~10-fold lower S100B levels compared to the control group (p \< 0.001; [Figure 5E](#F5){ref-type="fig"}). These data suggest that S100B modulates spontaneous Ca^2+^ fluctuations in DS astroglia.

Given the reported role of secreted S100B protein in modulating neural activity, we incubated the cultures with antibodies against S100B or Tuj1 (without permeabilization). After 10 min incubation, there was no effect on spontaneous Ca^2+^ events of either antibody ([Figure 5G](#F5){ref-type="fig"}), suggesting that the spontaneous Ca^2+^ events are mediated by intracellular S100B.

We then asked whether overexpression of S100B protein would also modulate spontaneous Ca^2+^ fluctuations. We observed 2-fold increase in the number of Ca^2+^ transients when S100B was overexpressed in DS1A ([Figures 5H and 5I](#F5){ref-type="fig"}; p \< 0.01), in which the number of spontaneous Ca^2+^ transients is less abundant than DS4A.

Finally, we examined whether DS astroglia with spontaneous Ca^2+^ fluctuations alleviated by *S100B* KD still suppressed neuronal excitability. We recorded evoked Ca^2+^ events in response to FP stimuli in H9 neurons co-cultured with DS4A with or without *S100B* KD. H9 neurons co-cultured with DS4A with potent *S100B* KD displayed significantly larger (1.7-fold; p \< 0.01) neural activity than those without *S100B* KD ([Figure 5J](#F5){ref-type="fig"}) suggesting that *S100B* KD successfully rescued neuronal activity suppressed by DS4A. Thus, we conclude that blocking Ca^2+^ fluctuations in DS astroglia by genetic ablation of either *IP*~*3*~*R2* oi *S100B* is sufficient to rescue the excitability decreases o co-cultured neurons.

DISCUSSION {#S11}
==========

Combining human stem cell technology with Ca^2+^ imaging and quantitative analysis tools provides a powerful platform to study neuron-astrocyte interaction in both physiological and pathological conditions, especially at early developmental stages. Using this platform, we imaged and characterized the effect of Ts21-iPSC-derived astroglia on neuronal networks. DS astroglia produced structural and functional deficits in co-cultured neurons Specifically, neurons co-cultured with DS astroglia displayed decreased global excitability. Such decreased global excitability of neurons corresponded with increased amplitudes of post-synaptic activity and synaptic density, consistent with accepted mechanisms of homeostatic synaptic plasticity and synaptic scaling ([@R46]). Our data are in line with a rodent DS model study, in which the dendritic spine density and mEPSC amplitude increased although frequency of mEPSCs remained unchanged in prefrontal cortical pyramidal neurons ([@R42]). Though abnormal synaptic morphology, such as reduced synaptic density, has been reported in other iPSC-derived DS models and in Ts65Dn adult mice, none of these studies have examined the function of astrocytes and potential effect imposed by astrocytes at early stages of brain development. Therefore, the effect of DS astrocytes on synaptic properties is worth further investigating across the whole spectrum of neuronal differentiation and development in iPSC-based DS models. In addition, transplantation of DS astrocytes into rodent models can be performed to directly examine the effect imposed by astrocytes on synaptic properties at early stages of brain development.

We further showed functional differences between DS astroglia and control isogenic astroglia in terms of intracellular Ca^2+^ dynamics. We observed elevated spontaneous Ca^2+^ fluctuations that are frequent and periodic only in DS-derived astroglia, but not in an isogenic control cell. These aberrant Ca^2+^ fluctuations in DS astroglia are necessary to drive suppression of global excitability in co-cultured neurons, as evidenced by rescue by genetic or pharmacological block.

What causes aberrant Ca^2+^ fluctuations in DS astroglia? Here, we demonstrate that overexpression of cellular S100B in DS astroglia mediates elevated spontaneous Ca^2+^ fluctuations ([Figures 5H and 5I](#F5){ref-type="fig"}), which subsequently regulate neuronal excitability ([Figure 5J](#F5){ref-type="fig"}). This finding is of particular interest, as S100B is a Ca^2+^-binding protein. Previous research ([@R6]) has shown that secreted S100B stimulates a rise in intracellular Ca^2+^ concentration in both neurons and glia. Furthermore, extracellular S100B regulates the firing patterns of neurons by reducing extracellular Ca^2+^ concentrations ([@R31]). In our studies, extracellular S100B did not influence spontaneous Ca^2+^ fluctuations in DS astroglia, whereas cytosolic of S100B did. Further investigation is necessary to parse the various functions of secreted and cytosolic S100B in healthy and disease model astrocytes and neurons.

A major open question in DS research is the mechanism by which the overdose of hundreds of genes on HSA21 disrupts brain function. To date, several candidate genes have been identified, including *DYRK1A, SIM2, DSCAM, KCNJ6, NKCC1,* and *miR-155* ([@R16]; [@R19]; [@R49]; [Table S1](#SD1){ref-type="supplementary-material"}). Overexpression of S100B, at the distal end of the HSA21 long arm, has been shown to generate reactive oxygen species (ROS) ([@R20]) in human induced pluripotent stem cells (hiPSC)-derived DS astroglia, leading to neuronal apoptosis ([@R14]). Previous research reported that ROS induce lipid peroxidation, activate the PLC-IP~3~R pathway, and cause Ca^2+^ increases in astrocytes ([@R47]). Indeed, we found that spontaneous Ca^2+^ activity was mediated by IP~3~R2-regulated ER stores. Though we do not have direct evidence to link S100B, ROS, and PLC-IP~3~R, S100B might mediate perturbed Ca^2+^ dynamics via ROS in DS astroglia.

Our study provides additional evidence to support the hypothesis that astrocytic Ca^2+^ signaling modulates neural activity, critical for brain function during development. A grand challenge is to elucidate the pathways regulating astrocyte-neuron interplay during development. In the present study, our results indicate that astrocyte-neuron interaction via purinergic signaling might be a significant contributor linking aberrant astrocytic Ca^2+^ to neuronal functional deficits in DS. We showed that treatment with 100 μM adenosine in H9 hESC-derived neurons without the presence of astrocytes suppressed neuronal activity. Furthermore, treatment with DPCPX, an adenosine A~1~ receptor antagonist, rescued the suppressed Ca^2+^ activity of H9 hESC-derived neurons co-cultured with DS astroglia ([Figure 1I](#F1){ref-type="fig"}). Previous research has shown that adenosine predominantly inhibits synaptic activity via A~1~ receptors ([@R17]; [@R25]; [@R34]). However, future efforts should focus on further elucidating the source of release and other co-factors involved in the neuronal inhibition.

In conclusion, the combination of a human iPSC DS model with functional imaging and pharmacological and genetic manipulation provides a platform for quantitative measurement of human cellular physiology and for mechanistic studies of disease pathophysiology. Though animal models of neurological disorders play an important role in studying the effects of specific genetic and experimental perturbations and in testing potential treatments, they often fail to faithfully recapitulate the full spectrum of human phenotypes, which can lead to false conclusions owing to molecular and cellular differences between the systems. Future improvements to iPSC models will include 3-dimensional culture ([@R38]), multi-color imaging, and incorporating genetically encoded indicators for other molecules and cellular states (e.g., glutamate; [@R29]). Our imaging platform can be applied to the study of other neurological diseases as well, even to the level of testing specific drug combinations on neuron-astrocyte co-cultures developed from single healthy or diseased individuals.

EXPERIMENTAL PROCEDURES {#S12}
=======================

Neural Differentiation of Human ESCs and iPSCs {#S13}
----------------------------------------------

H9 human ESCs were obtained from WiCell (Madison, WI). Control isogenic trisomy 21 and euploid iPSCs, DS1, DS2U, and DS4, were engineered in Dr. Anita Bhattacharyya's lab, as previously described ([@R51]). H9 ESCs and iPSCs were maintained on Matrigel (Becton Dickinson; 356234) in mTeSR1 medium (StemCell Technologies; 05850). Mycoplasma contamination was routinely tested. We used previously described protocols for neural differentiation ([@R54]), with minor modifications. Briefly, following detachment of neuroepithelia from adherent conditions at day 14, neurospheres were expanded in fibroblast growth factor (FGF)/epidermal growth factor (EGF) (10 ng/mL). Large spheres were disaggregated into smaller clusters approximately every two weeks until day 90. 20--25 neurospheres or 2.5 × 10^4^ cells/cm^2^ were seeded on 35-mm Matrigel-coated glass-bottom dishes (MatTek; P35G-1.0-14-C), and once confluent, neurospheres were cultured in neuronal medium (neurobasal medium, 21103-049; 1% N-2 supplement, 17502-048, 2% B-27 supplement, 17504-044; 10 ng/mL BDNF \[450-02\]; and GDNF \[450-10\]) for 40 days. Medium components were purchased from Thermo Fisher Scientific and cytokines from Peprotech. Inhibitors of SMAD signaling (10 μM SB431542 and 100 nM LDN193189; Tocris Bioscience) were added for the first 6 days to promote neural induction ([@R12]).

Derivation and Culture of Astrocytes {#S14}
------------------------------------

Control isogenic and DS iPSCs were differentiated into neural progenitors and cultured similar to neural differentiation with the following modifications. Astrospheres were then plated at a concentration of 500,000 cells/mL in 12 mL of media in T75 flasks and allowed to adhere to fibronectin-coated dishes (Sigma; F0895). After confluent, astrospheres were dissociated into single cells and cultured in an optimized commercial medium for human primary astrocytes (ScienCell Research Laboratories; 1801). HAs were from ScienCell Research Laboratories (1800). We performed karyotype analysis on DS1-, DS4-, and DS2U-derived astroglia, prior to and after the Ca^2+^ experiments (Cell Line Genetics). The cell size was analyzed by randomly selecting 5 cells from 3 bright field images (ImageJ).

Ca^2+^ Imaging and Analysis in Astrocytes {#S15}
-----------------------------------------

Primary astrocytes or iPSC-derived astrocytes were seeded onto 8-well slides (Ibidi; 80826), coated with fibronectin, and infected with lentiviruses encoding *EF1α*-GCaMP6m and then subjected to Ca^2+^ imaging. For *IP~3~R2* KD, DS4A cells were infected with lentiviruses encoding shRNA and GCaMP6m; Ca^2+^ imaging followed. For *S100B* KD, DS4A cells were infected with lentiviruses encoding shRNA, sorted into 2 populations by FACS according to mCherry intensity, and infected with GCaMP6m for each population; Ca^2+^ imaging followed. For each cell line, 3 Ca^2+^-imaging sessions (each session contains 3 fields of view) were collected from independent samples. For mixed cultures of control isogenic and DS astrocytes, control isogenic DS2UA were first infected with lentiviruses expressing *EF1α*-GCaMP6m and then seeded with DS4A, followed by Ca^2+^ imaging. Three days post-infection, frame scans were acquired at 2 Hz (512 × 512 pixels) for a period of 300 s. All imaging was done using a Zeiss LSM 710 confocal microscope (20x magnification; numerical aperture \[N.A.\] = 0.8 objective). Agonists or antagonists (Tocris) were added at frame 10 during continuous imaging. For quantification of ATP and glutamate-evoked activity, to eliminate the confound of spontaneous activity, only ROIs that were silent during the initial imaging period were analyzed for a response to added ATP or glutamate. Furthermore, we ensured that these evoked responses were time locked to agonist application.

Because of these complex spatiotemporal patterns of Ca^2+^ dynamics in astrocytes, we developed a computational tool (FASP; [@R50]) to quantitatively and automatically analyze the large-scale imaging datasets to ensure that the analysis is identical and objective for all cells and across experiments. Additional details are in the [Supplemental Information](#SD1){ref-type="supplementary-material"}.

Neuron-Astrocyte Co-culture and Astrocyte-Conditioned Media Incubation {#S16}
----------------------------------------------------------------------

Differentiated neurons were infected with lentiviruses expressing *Synapsin-1-*GCaMP6m. Two days post-infection, astrocytes were seeded on top of neurons to establish co-culture. Neurons were seeded with astrocytes at 1:1 at 5 × 10^4^ in 35 mm on glass bottom dishes in 2 mL of medium or with 100 μg/mL of astrocyte-conditioned media in 8-well μ-slide dishes in 250 μL of media. After 3--7 days, infected neurons were stimulated using a custombuilt field stimulator with platinum wires or 50 μM glutamate. Field stimuli were delivered as 40 V, 30 Hz, 1 ms pulses for the following trains: 10, 20, 40, and 80 field stimuli in Hank's balanced salt solution (HBSS) with 2 mmol CaCl~2~ and MgCl~2~. When chemicals were used, they were applied 3 days prior to imaging, except DPCPX and adenosine, which was acutely applied 1 hr prior to imaging. All chemicals were purchased from Tocris or Sigma.

Single-Cell Expression {#S17}
----------------------

DS astrocytes were digested and sorted by FACS to get rid of cell debris and dead cells. The cell suspension was loaded onto a C1 Single-Cell Auto Prep Array for mRNA Seq (10--17 μm; Fluidigm; 100-5760), and single cells were captured and lysed to get cDNA on Fluidigm's C1 platform. Gene expression patterns of single cells (n = 46) were studied using the 48.48 Dynamic Array Chip for Gene Expression following the manufacturer's instructions (Fluidigm; BMK-M48.48).

Animals {#S18}
-------

Animal studies were conducted in compliance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and approved by the Institutional Animal Care and Use Committee (IACUC) at the University of California, Davis or the relevant institutional regulatory body.

Statistical Analysis {#S19}
--------------------

All values are shown as mean ± SEM. To determine significant differences between groups, comparisons were made using a two-tailed unpaired t test. For mEPSC analysis, a one-way ANOVA was used to compare mEPSC amplitude and frequency among groups, followed by Fisher's least significant difference (LSD) pairwise comparison when appropriate. For single-cell expression analysis, a permutation test was applied for unsupervised clustering, and the differences of each gene between the two clusters were determined using two-sample unpaired Wilcoxon rank-sum test. A p value smaller than 0.05 was accepted for statistical significance p \< 0.01 (\*\*) or 0.05 (\*). The sample size for each experiment was determined either by power analysis (2-sample, 2-sided equality) or by referring to the sample size in similar studies ([@R14]; [@R55]). For Ca^2+^-imaging experiments, imaging sessions were collected from at least 3 batches of cells, and ROIs were selected either automatically by FASP for astrocyte Ca^2+^ imaging or manually for neuronal Ca^2+^ imaging. For gene expression, RNA samples from three batches of cells were used. For immunostaining analysis, three batches of cells were fixed and five fields of view from each sample were selected for imaging and analyzed blinded. No randomization was used. No data were excluded.
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![DS Astroglia Inhibit Neuronal Excitability during Co-culture\
(A) The fluorescence changes (ΔF/F) of H9 hESC-derived neurons in response to a variety of FP stimuli; ΔF/F at 10 FPs, 40 FPs, and 40 FPs in the presence of 1 μM TTX were normalized to ΔF/F at 80 FPs.\
(B--D) The responses of H9 hESC- (B), isogenic DS2U- (C), and DS1-iPSC- (D) derived neurons to FP stimuli (40 FPs at 30 Hz) when co-cultured with or without astroglia. ΔF/F induced by FP stimuli in the presence of astrocytes was normalized to that of neurons alone (red dotted lines). Representative traces showing Ca^2+^ transients triggered by FPs in neurons are shown (right panel).\
(E) Example recordings of mEPSCs from 1 neuron from each group.\
(F) Cumulative probability of the mEPSC amplitude shifted rightward in both DS4A and DS1A groups compared with the DS2UA group.\
(G) No change was seen in the cumulative probability of the mEPSC inter-event interval.\
(H) Representative images and quantification of puncta density expressing both synapsin and PSD95 (n = 3 images of immunostaining).\
(I) The fluorescence changes of H9 hESC-derived neurons in response to 40 FPs stimuli when co-cultured with DS4A in the presence of DMSO or a series of drugs are shown and normalized to changes when co-cultured with DS2UA. For each cell line, n = 3 Ca^2+^-imaging sessions (each session contains 3 fields of view). Error bars are shown as mean ± SEM, \*p \< 0.05, \*\*p \< 0.01.](nihms-1500937-f0002){#F1}

![Imaging Ca^2+^ Events in Human-iPSC-Derived Isogenic and DS Astroglia\
(A) Spontaneous Ca^2+^ responses in isogenic DS2UA and two DS astroglia (DS1A and DS4A). Representative ROIs (n = 20) in the field of view showing Ca^2+^ fluctuations in DS2UA, DS1A, and DS4A. All ROIs were detected using FASP and marked with magenta outlines. The scale bar represents 100 μm.\
(B) DS1A and DS4A displayed a significantly increased number of Ca^2+^ fluctuations in 5 min of imaging sessions compared with DS2UA (9 independent imaging sessions).\
(C--E) Features of Ca^2+^ fluctuations in DS astroglia: averaged kinetics (C), frequency (D), and propagation speed (E) of DS astroglia. Data were collected from 81 cells of DS1A and 188 cells of DS4A.\
(F--I) The Ca^2+^ fluctuations in DS4A could be abolished by incubation with IP3R antagonist (500 μM 2-APB; 17 ROIs; F and H) ordepleting ER Ca^2+^ store (20 μM CPA; 23 ROIs; G and I).\
Error bars are shown as mean ± SEM, \*p \< 0.05, \*\*p \< 0.01.](nihms-1500937-f0003){#F2}

![DS Astroglial Ca^2+^ Fluctuations Are Regulated by IP~3~R-ER Pathway\
(A--C) The Ca^2+^ events in DS4A were significantly decreased by knocking down the expression of *IP~3~R.* Representative ROIs (n = 20) showing Ca^2+^ fluctuations in DS4A expressing scrambled shRNA (ctrl shRNA) and two shRNAs for *IP~3~R* (IP~3~R shRNA-1/2; A). Real-time PCR confirmed the decreased expression of *IP~3~R* in the presence of *IP~3~R* shRNAs (3 RNA samples; B), corresponding to a decreased number of Ca^2+^ events in 5 min (3 imaging sessions; C).\
(D) Normalized fluorescence changes of H9 hESC-derived neurons in responseto 40 FPs co-cultured with DS4A or DS4A expressing scrambled or *IP~3~R* shRNAs to those of neurons alone (dotted red line).\
Error bars are shown as mean ± SEM, \*p \< 0.05, \*\*p \< 0.01.](nihms-1500937-f0004){#F3}

![Spontaneous Fluctuations in DS Astroglia Could Not Be Modulated by Pharmacological Manipulation\
(A) ATP increased the frequency and amplitude of Ca^2+^ events in previously active cells (20 ROIs; p \< 0.01).\
(B and C) Purinergic receptor antagonist (20 μM PPADS; 25 ROIs, B; and 20 μM suramin; 18 ROIs, C) failed to modulate the Ca^2+^ fluctuations in DS4A.\
(D--F) A1 adenosine receptor antagonist (DPCPX 20 μM; 18 ROIs; D), mGluR5 antagonist (10 μM MPEP; 42 ROIs; E), and TRPA inhibitor (50 μM HC030031; 20 ROIs; F) failed to modulate the Ca^2+^ fluctuations in DS4A. (Left) Representative traces are shown. (Right) Quantification of amplitude, frequency, and kinetics is shown.\
\*p \< 0.01, \*\*p \< 0.01.](nihms-1500937-f0005){#F4}

![S100B Regulates Spontaneous Ca^2+^ Fluctuations in DS Astroglia\
(A and B) Immunostaining of S100B in iPSC-derived astroglia (A) revealed increased expression in DS astroglia normalized to isogenic DS2UA (three images of immunostaining; 12.5% ± 1.0% for DS2UA; 80.4% ± 1.8% for DS1A; 75.3% ± 2.9% for DS4A; p \< 0.01; B). Scale bar: 10 μm.\
(C) Schematic representation of lentiviral construct encoding *S100B* shRNA-nls-mCherry. Scale bar: 50 μm.\
(D) Representative ROIs (n = 20) highlighted in (C) showing spontaneous Ca^2+^ fluctuations in populations of DS4A without (left) and with *S100B* KD (right). The scale bars represent 50 μm.\
(E and F) The *S100B* expression levels normalized to without *S100B* KD (3 RNA samples; E) and the number of Ca^2+^ events (3 imaging sessions of 5 min; F) with and without *S100B* KD are shown.\
(G) Extracellular application of anti-S100B antibody did not influence the number of spontaneous Ca ^2+^ fluctuations in DS4A (3 imaging sessions).\
(H and I) Overexpression of S100B increased the number of Ca^2+^ events in DS1A. qPCR analysis confirmed elevated expression of S100B in DS1A when S100B was overexpressed (3 RNA samples; 4.8- ± 0.2-fold normalized to empty vector group; p \< 0.01; H). 2-fold more Ca^2+^ events in 5 min were detected in DS1A when S100B was overexpressed normalized to control (3 imaging sessions; I).\
(J) Blocking intracellular Ca^2+^ events by *S100B* KD increased activity of H9 hESC-derived neurons co-cultured with DS4A. The fluorescence changes of H9 hESC-derived neurons in response to 40 FPs stimuli co-cultured with DS4A with *S100B* shRNA normalized to DS4A with control shRNA are shown. Error bars are shown as mean ± σEM, \*p \< 0.05, \*\*p \< 0.01.](nihms-1500937-f0006){#F5}

###### Highlights

-   Neuron-astrocyte interactions in a human DS stem cell model

-   DS astroglia exhibited more frequent spontaneous Ca^2+^ fluctuations

-   Spontaneous DS astroglia Ca^2+^ reduced excitability of co-cultured neurons

-   Abolishing astrocytic spontaneous Ca^2+^ rescued suppressed neuronal activity
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